These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28232269)

  • 1. New gonadotropin-releasing hormone glycolipids with direct antiproliferative activity and gonadotropin-releasing potency.
    Varamini P; Mansfeld FM; Giddam AK; Steyn F; Toth I
    Int J Pharm; 2017 Apr; 521(1-2):327-336. PubMed ID: 28232269
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer.
    Gründker C; Emons G
    Reprod Biol Endocrinol; 2003 Oct; 1():65. PubMed ID: 14594454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of New Gonadotropin-Releasing Hormone-Modified Dendrimer Platforms with Direct Antiproliferative and Gonadotropin Releasing Activity.
    Varamini P; Rafiee A; Giddam AK; Mansfeld FM; Steyn F; Toth I
    J Med Chem; 2017 Oct; 60(20):8309-8320. PubMed ID: 28958147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of gonadotropin-releasing hormone-I agonist and gonadotropin-releasing hormone-II on endometrial carcinoma cell lines with different states of PTEN].
    Zhao LJ; Wei LH; Li XP; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):45-9. PubMed ID: 19563062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer activity of a new gonadotropin releasing hormone analogue.
    Saleh-Abady MM; Naderi-Manesh H; Alizadeh A; Shamsipour F; Balalaie S; Arabanian A
    Biopolymers; 2010; 94(3):292-7. PubMed ID: 19908246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor--positive human cancer cell lines.
    Pályi I; Vincze B; Kálnay A; Turi G; Mezõ I; Teplán I; Seprõdi J; Pató J; Móra M
    Cancer Detect Prev; 1996; 20(2):146-52. PubMed ID: 8706040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative effects of the GnRH antagonist cetrorelix and of GnRH-II on human endometrial and ovarian cancer cells are not mediated through the GnRH type I receptor.
    Gründker C; Schlotawa L; Viereck V; Eicke N; Horst A; Kairies B; Emons G
    Eur J Endocrinol; 2004 Jul; 151(1):141-9. PubMed ID: 15248835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
    Gründker C; Völker P; Schulz KD; Emons G
    Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.
    Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H
    Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation.
    Gründker C; Günthert AR; Millar RP; Emons G
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1427-30. PubMed ID: 11889221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of gonadotropin-releasing hormone (GnRH) receptor-I expression in the pituitary and ovary by a GnRH agonist and antagonist.
    Mo Y; Peng P; Zhou R; He Z; Huang L; Yang D
    Reprod Sci; 2010 Jan; 17(1):68-77. PubMed ID: 19861704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actions of gonadotropin-releasing hormone analogues in pituitary gonadotrophs and their modulation by ovarian steroids.
    Weiss JM; König SJ; Polack S; Emons G; Schulz KD; Diedrich K; Ortmann O
    J Steroid Biochem Mol Biol; 2006 Oct; 101(2-3):118-26. PubMed ID: 16891115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats.
    Kovacs M; Schally AV
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12197-202. PubMed ID: 11593037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity.
    Teplán I
    Acta Biol Hung; 2000; 51(1):1-29. PubMed ID: 10866357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of gonadotropin-releasing hormone (GnRH) receptor gene is altered by GnRH agonist desensitization in a manner similar to that of gonadotropin beta-subunit genes in normal and castrated rat pituitary.
    Lerrant Y; Kottler ML; Bergametti F; Moumni M; Blumberg-Tick J; Counis R
    Endocrinology; 1995 Jul; 136(7):2803-8. PubMed ID: 7789305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of GnRH analogs having direct antitumor and low LH-releasing activity.
    Mezô I; Seprôdi J; Vincze B; Pályi I; Kéri G; Vadász Z; Tóth G; Kovács M; Koppán M; Horváth JE; Kálnay A; Teplán I
    Biomed Pept Proteins Nucleic Acids; 1996; 2(2):33-40. PubMed ID: 9346824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [APPLICATION OF DIFERELIN AND ITS PERSPECTIVES].
    Rapoport LM; Bezrukov EA; Demidko JL; Kondrashina AV
    Urologiia; 2015; (2):43-4, 46. PubMed ID: 26237805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor.
    Tkalia IG; Vorobyova LI; Grabovoy AN; Svintsitsky VS; Tarasova TO; Lukyanova NY; Todor IN; Chekhun VF
    Exp Oncol; 2014 Sep; 36(3):184-90. PubMed ID: 25265352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of mimetics of gonadotropin releasing hormone (GnRH) with effects on proliferation of breast cancer cells.
    Moore GJ; Pires JM; Hayden LJ
    Proc West Pharmacol Soc; 1999; 42():87-90. PubMed ID: 10697699
    [No Abstract]   [Full Text] [Related]  

  • 20. Gonadotrophin hormone releasing analogues open new doors in cancer treatment.
    Waxman J
    Br Med J (Clin Res Ed); 1987 Oct; 295(6606):1084-5. PubMed ID: 2961401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.